Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. News/
  3. What you need to know about Johnson & Johnson’s first-quarter 2026 earnings report
Johnson & Johnson doctor in a medical office working with a patient

What you need to know about Johnson & Johnson’s first-quarter 2026 earnings report

Check out this infographic breakdown of the company’s first-quarter performance, with highlights from its Innovative Medicine and MedTech businesses.

This morning, Johnson & Johnson shared its first-quarter 2026 earnings report.

Since its founding in 1886, the company has been committed to innovation—today, approximately 140,000 employees across the globe work to deliver solutions for patients around the world to help profoundly impact health for humanity.

“Johnson & Johnson delivered a solid quarter while advancing our portfolio and investing in our new launches to accelerate growth over the long term,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “With a strong financial foundation, we continue investing in innovative science and technology, managing the portfolio with discipline and returning capital to shareholders, underscored by today’s announcement increasing our dividend for the 64th consecutive year.”

For more details about the company’s first-quarter 2026 results and to read a message from Chairman and Chief Executive Officer Joaquin Duato, here’s an infographic highlighting key stats.

Infographic of Johnson & Johnson's first-quarter 2026 earnings results. 2026 first-quarter reported sales growth of 9.9% to $24.1 billion with operational growth of 6.4%. 2026 first-quarter reflects earnings per share (EPS) of $2.14 and adjusted EPS of $2.70.

Johnson & Johnson’s first-quarter 2026 earnings

Read the earnings press release, which includes first-quarter financial data for 2026.

Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.